SPONSOR
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Esophageal Squamous Cell Carcinoma, Colorectal Cancer, Liver Metastasis, LDRT.
The trial portfolio spans Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
How many clinical trials has Daping Hospital and the Research Institute of Surgery of the Third Military Medical University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, of which 2 are actively recruiting participants. These trials cover conditions including Esophageal Squamous Cell Carcinoma, Colorectal Cancer, Liver Metastasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Daping Hospital and the Research Institute of Surgery of the Third Military Medical University research focus on?
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University clinical trials span Esophageal Squamous Cell Carcinoma, Colorectal Cancer, Liver Metastasis, LDRT. The research pipeline includes Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Daping Hospital and the Research Institute of Surgery of the Third Military Medical University clinical trial?
To participate in a Daping Hospital and the Research Institute of Surgery of the Third Military Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Daping Hospital and the Research Institute of Surgery of the Third Military Medical University trials with current recruitment status updated daily.
Clinical Trials by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
NCT06354140 Phase 2
Recruiting
PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
Esophageal Squamous Cell Carcinoma
NCT06848465 Phase 1
Recruiting
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Colorectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology